Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

FORGOTTEN HISTORY: What to expect from merck co s q4 2024 earnings report | History Defined

With a market cap of $252.6 billion, Rahway, New Jersey-based Merck & Co., Inc. (MRK) is a global leader in the healthcare industry, operating through its Pharmaceutical and Animal Health segments. The company is known for its innovative products, including Keytruda, Gardasil, and a variety of treatments in oncology, immunology, and infectious diseases, as well as its commitment to advancing healthcare solutions through strategic partnerships and acquisitions. It is expected to unveil its fiscal Q4 earnings results before the market opens on Tuesday, Feb. 4.

Before the event, analysts anticipated the pharmaceutical company to report a profit of $1.76 per share, a substantial increase from $0.03 per share in the same quarter last year. The company has consistently surpassed Wall Street's earnings projections in the past four quarters. MRK exceeded the consensus estimate by 4.7% in the last reported quarter.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.